You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IMC-001-201

Showing 1 - 25 of 2,190
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Advanced Digestive System Tumor Trial in China (IMC001 injection)

Not yet recruiting
  • Advanced Digestive System Tumor
  • IMC001 injection
  • Beijing, Beijing, China
  • +6 more
Jul 12, 2023

Tumor, Solid Trial in Morristown, Houston (BDB001)

Active, not recruiting
  • Tumor, Solid
  • Morristown, New Jersey
  • +1 more
Nov 9, 2021

Stage III Prostate Carcinoma, Stage IV Prostate Carcinoma Trial (VAL201)

Completed
Has Results
  • Stage III Prostate Carcinoma
  • Stage IV Prostate Carcinoma
  • (no location specified)
Oct 8, 2021

Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • EPCAM CAR-T
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022

Solid Tumor, Metastasis, Locally Advanced Trial in Yongin-si (IMC-001)

Completed
  • Solid Tumor
  • +2 more
  • Yongin-si, Gyeonggi-do, Korea, Republic of
    ImmuneOncia
May 26, 2020

COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)

Completed
  • COVID-19
  • BRII-196
  • +3 more
  • Tucson, Arizona
  • +106 more
Mar 24, 2023

COVID-19 Trial in Worldwide (LY3819253, Placebo, Remdesivir)

Completed
  • COVID-19
  • LY3819253
  • +2 more
  • Tucson, Arizona
  • +56 more
Mar 22, 2023

COVID-19 Trial in Worldwide (VIR-7831, Placebo, Remdesivir)

Completed
  • COVID-19
  • VIR-7831
  • +2 more
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • AZD7442
  • +2 more
  • Tucson, Arizona
  • +123 more
Mar 24, 2023

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • CABA-201
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 7, 2023

Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)

Completed
  • Covid19
  • Remdesivir
  • +4 more
  • Tucson, Arizona
  • +39 more
Dec 16, 2022

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Oral zamicastat)

Completed
  • Pulmonary Arterial Hypertension
  • Oral zamicastat
  • Linz, Austria
  • +10 more
Aug 18, 2023

Respiratory Depression Trial (ENA-001)

Not yet recruiting
  • Respiratory Depression
  • (no location specified)
Nov 17, 2023

Type 1 Diabetes, Diabetes, Type 1 Trial in Miami (CELZ-201 Administration, Control Group)

Not yet recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • CELZ-201 Administration
  • Control Group
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Nov 15, 2022

Glioblastoma Trial (RZ-001, VGCV)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Oct 22, 2023

Malignant Tumor Trial in Beijing (NV-001)

Not yet recruiting
  • Malignant Neoplasm
  • NV-001
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 21, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

Diffuse Intrinsic Pontine Glioma Trial in Phoenix, San Francisco, Washington (SONALA-001 (ALA) and MR-Guided Focused Ultrasound

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)
  • Phoenix, Arizona
  • +2 more
Jan 4, 2023

Epilepsy Trial in Boise, Bethesda (Placebo, EQU-001)

Completed
  • Epilepsy
  • Boise, Idaho
  • +1 more
Jan 30, 2023

Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)

Recruiting
  • Dry Eye Syndromes
  • SCAI-001 0.01% eyedrop
  • +2 more
  • Bucheon, Korea, Republic of
  • +10 more
Feb 21, 2023

Respiratory Syncytial Virus Infections Trial in Cincinnati, North Charleston (CPI-RSV-F Vaccine (BLB-201))

Completed
  • Respiratory Syncytial Virus Infections
  • CPI-RSV-F Vaccine (BLB-201)
  • Cincinnati, Ohio
  • +1 more
Dec 5, 2022